National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 75357 [2013-29468]

Download as PDF Federal Register / Vol. 78, No. 238 / Wednesday, December 11, 2013 / Notices development of evidence-based guidelines and tested/validated intervention tools; (5) training professionals; and (6) building capacity for systems of services in states. Likely Respondents: Grantees funded by HRSA under the CAAI will be the respondents for this data collection activity. The programs to be evaluated are listed below. • 20 R40 Maternal and Child Health (MCH) Autism Intervention Research Program grantees that support research on evidence-based practices for interventions to improve the health and well-being of children and adolescents with ASD and other DD. 3. State Implementation Program Grants for Improving Services for Children and Youth With ASD and Other DD 1. Training Programs • Nine grantees will implement state • Leadership Education in autism plans and develop models for Neurodevelopmental Disabilities improving the system of care for (LEND) training programs with fortychildren and youth with ASD and other three grantees; • Developmental Behavioral DD; • Four grantees will design state Pediatrics (DBP) training programs with plans for improving the system for ten grantees; and • A National Combating Autism children and youth with ASD and other Interdisciplinary Training Resource DDs; and • A State Public Health Coordinating Center grantee. Resource Center grantee. 2. Research Networks Program The data gathered through this • Three Autism Intervention Research evaluation will be used to: • Evaluate the grantees’ performance Networks that focus on intervention in achieving the objectives of the CAAI research, guideline development, and during the three year grant period; information dissemination; and 75357 • Assess the short- and intermediateterm impacts of the grant programs on children and families affected by ASD and other DD; and • Measure the CAAI outputs and outcomes for the Report to Congress. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of respondents Grant program/form name Number of responses per respondent Average burden per response (in hours) Total responses Total burden hours LEND interview Protocol .................................................. DBP Interview Protocol .................................................... State Implementation Program Interview Protocol 1 ........ State Implementation Program Questionnaire ................ Research Network Interview Protocol ............................. Research Program R40 Interview Protocol ..................... Research Network Questionnaire .................................... Resource Centers Interview Protocol .............................. 43 10 13 13 3 20 3 2 1 1 1 1 1 1 1 1 43 10 13 13 3 20 3 2 1 1 1 .75 1 1 3 1 43 10 13 9.75 3 20 9 2 Total .......................................................................... 107 ........................ 107 .......................... 109.75 1 Although a total of 22 state grants have been awarded to date, states that were awarded grants in 2008 and 2009 were interviewed during the previous evaluation. We are seeking clearance to interview only the 13 states that were awarded grants in 2011. Dated: December 5, 2013. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2013–29509 Filed 12–10–13; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES emcdonald on DSK67QTVN1PROD with NOTICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. VerDate Mar<15>2010 17:00 Dec 10, 2013 Jkt 232001 The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44) and Clinical Trial Planning Grant (R34). Date: January 7, 2014. Time: 12:00 p.m. to 4:00 p.m. PO 00000 Frm 00029 Fmt 4703 Sfmt 9990 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room 3131, 6700–B Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Betty Poon, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301– 402–6891, poonb@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS). Dated: December 4, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–29468 Filed 12–10–13; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\11DEN1.SGM 11DEN1

Agencies

[Federal Register Volume 78, Number 238 (Wednesday, December 11, 2013)]
[Notices]
[Page 75357]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-29468]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial 
Implementation Cooperative Agreement (U44) and Clinical Trial 
Planning Grant (R34).
    Date: January 7, 2014.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Room 3131, 6700-B 
Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Betty Poon, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 
301-402-6891, poonb@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS).

    Dated: December 4, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-29468 Filed 12-10-13; 8:45 am]
BILLING CODE 4140-01-P